Epigenome-wide DNA methylation changes with development of arsenic-induced skin lesions in Bangladesh: A case-control follow-up study

Environmental and Molecular Mutagenesis

Volumn 55, Issue 6, 2014, Pages 449-456

  Seow, Wei Jie ^a   Kile, Molly L ^b   Baccarelli, Andrea A ^a   Pan, Wen Chi ^a   Byun, Hyang Min ^a   Mostofa, Golam ^c   Quamruzzaman, Quazi ^c   Rahman, Mahmuder ^c   Lin, Xihong ^a   Christiani, David C ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c Dhaka Community Hospital   (Bangladesh)

Author keywords

Arsenic; DNA methylation; Illumina 450K; Longitudinal; Skin lesion

Indexed keywords

ARSENIC; CYTOSINE; CYTOSINE PHOSPHATE GUANINE; DRINKING WATER; GUANINE; PHOSPHATE; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR; RHBDF1 PROTEIN, HUMAN; WATER POLLUTANT;

ADULT; ARTICLE; BANGLADESH; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MALE; PYROSEQUENCING; QUESTIONNAIRE; SKIN DEFECT; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED; CHEMISTRY; CPG ISLAND; DNA MICROARRAY; DNA SEQUENCE; DRUG EFFECTS; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; SKIN DISEASE; TOXICITY; WATER POLLUTANT;

ARSENIC; BANGLADESH; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; DRINKING WATER; EPIGENESIS, GENETIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; QUESTIONNAIRES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SEQUENCE ANALYSIS, DNA; SKIN DISEASES; WATER POLLUTANTS, CHEMICAL;

EID: 84903816327     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.21860     Document Type: Article

References (38)

1. Baccarelli A, Bollati V. 2009. Epigenetics and environmental chemicals. Curr Opin Pediatr 21:243-251.
2. Baylin, SB. 2005. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2(Suppl 1):S4-S11.
3. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate - A practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57:289-300.
4. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, Byun HM, Jiang J, Marinelli B, Pesatori AC, et al. 2007. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 67:876-880.
5. Breton CV, Houseman EA, Kile ML, Quamruzzaman Q, Rahman M, Mahiuddin G, Christiani DC. 2006. Gender-specific protective effect of hemoglobin on arsenic-induced skin lesions. Cancer Epidem Biomark Prev 15:902-907.
6. Cantone I, Fisher AG. 2013. Epigenetic programming and reprogramming during development. Nat Struct Mol Biol 20:282-289.
7. Centeno JA, Mullick FG, Martinez L, Page NP, Gibb H, Longfellow D, Thompson C, Ladich ER. 2002. Pathology related to chronic arsenic exposure. Environ Health Persp 110(Suppl 5):883-886.
8. Chowdhury UK, Biswas BK, Chowdhury TR, Samanta G, Mandal BK, Basu GC, Chanda CR, Lodh D, Saha KC, Mukherjee SK, et al. 2000. Groundwater arsenic contamination in Bangladesh and West Bengal, India. Environ Health Persp 108:393-397.
9. Du C, Huang T, Sun D, Mo Y, Feng H, Zhou X, Xiao X, Yu N, Hou B, Huang G, et al. 2011. CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma. Cancer Lett 309:54-61.
10. Du P, Zhang X, Huang CC, Jafari N, Kibbe WA, Hou L, Lin SM. 2010. Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics 11:587.
11. Feil R. 2006. Environmental and nutritional effects on the epigenetic regulation of genes. Mutat Res 600:46-57.
12. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suñer D, Cigudosa JC, Urioste M, Benitez J, et al. 2005. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102:10604-10609.
13. Hou L, Zhang X, Wang D, Baccarelli A. 2012. Environmental chemical exposures and human epigenetics. Int J Epidemiol 41:79-105.
14. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, Wiencke JK, Kelsey KT. 2012. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13:86.
15. Johnson WE, Li C, Rabinovic A. 2007. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8:118-127.
16. Kile ML, Baccarelli A, Hoffman E, Tarantini L, Quamruzzaman Q, Rahman M, Mahiuddin G, Mostoa G, Hsueh YM, Wright RO, et al. 2012. Prenatal arsenic exposure and DNA methylation in maternal and umbilical cord leukocytes. Environ Health Persp 120:1061-1066.
17. Leek JT, Johnson EW, Parker HS, Jaffe AE, Storey JD. 2012. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28:882-883.
18. Liu Q, Zhang H, Smeester L, Zou F, Kesic M, Jaspers I, Pi J, Fry RC. 2010. The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genom 3:37.
19. Millington GWM. 2008. Epigenetics and dermatological disease. Pharmacogenomics 9:1835-1850.
20. Miotto E, Sabbioni S, Veronese A, Calin GA, Gullini S, Liboni A, Gramantieri L, Bolondi L, Ferrazzi E, Gafa R, et al. 2004. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer Res 64:8156-8159.
21. Nakagawa T, Guichard A, Castro CP, Xiao Y, Rizen M, Zhang HZ, Hu D, Bang A, Helms J, Bier E, et al. 2005. Characterization of a human rhomboid homolog, p100hRho/RHBDF1, which interacts with TGF-alpha family ligands. Dev Dyn 233:1315-1331.
22. Pilsner JR, Liu X, Ahsan H, Ilievski V, Slavkovich V, Levy D, Factor-Litvak P, Graziano JH, Gamble MV. 2009. Folate deficiency, hyperhomocysteinemia, low urinary creatinine, and hypomethylation of leukocyte DNA are risk factors for arsenic-induced skin lesions. Environ Health Persp 117:254-260.
23. Reichard JF, Puga A. 2010. Effects of arsenic exposure on DNA methylation and epigenetic gene regulation. Epigenomics 2:87-104.
24. Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L. 2011. An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Persp 119:11-19.
25. Schulz WA. 2006. L1 retrotransposons in human cancers. J Biomed Biotechnol 2006:83672.
26. Sciandrello G, Caradonna F, Mauro M, Barbata G. 2004. Arsenic-induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis 25:413-417.
27. Seow WJ, Pan WC, Kile ML, Baccarelli AA, Quamruzzaman Q, Rahman M, Mahiuddin G, Mostofa G, Lin X, Christiani DC. 2012. Arsenic reduction in drinking water and improvement in skin lesions: A follow-up study in Bangladesh. Environ Health Persp 120:1733-1738.
28. Slotkin RK, Martienssen R. 2007. Transposable elements and the epigenetic regulation of the genome. Nat Rev Genet 8:272-285.
29. Smeester L, Rager JE, Bailey KA, Guan XJ, Smith N, Garcia-Vargas G, Del Razo LM, Drobná Z, Kelkar H, Stýblo M, et al. 2011. Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol 24:165-167.
30. Smith AH, Lingas EO, Rahman M. 2000. Contamination of drinking-water by arsenic in Bangladesh: A public health emergency. Bull World Health Org 78:1093-1103.
31. Thomas JH, Emerson RO, Shendure J. 2009. Extraordinary molecular evolution in the PRDM9 fertility gene. PLoS One 4:e8505.
32. Touleimat N, Tost J. 2012. Complete pipeline for Infinium((R)) human methylation 450K beadchip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics 4:325-341.
33. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40:453-463.
34. van Bemmel D, Lenz P, Liao LM, Baris D, Sternberg LR, Warner A, Johnson A, Jones M, Kida M, Schwenn M, et al. 2012. Correlation of LINE-1 methylation levels in patient-matched buffy coat, serum, buccal cell, and bladder tumor tissue DNA samples. Cancer Epidemiol Biomark Prev 21:1143-1148.
35. Yan Z, Zou H, Tian F, Grandis JR, Mixson AJ, Lu PY, Li LY. 2008. Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth. Mol Cancer Ther 7:1355-1364.
36. Yuen RK, Peñaherrera MS, von Dadelszen P, McFadden DE, Robinson WP. 2010. DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet 18:1006-1012.
37. Zettl M, Adrain C, Strisovsky K, Lastun V, Freeman M. 2011. Rhomboid family pseudoproteases use the ER quality control machinery to regulate intercellular signaling. Cell 145:79-91.
38. Zou H, Thomas SM, Yan ZW, Grandis JR, Vogt A, Li LY. 2009. Human rhomboid family-1 gene RHBDF1 participates in GPCR-mediated transactivation of EGFR growth signals in head and neck squamous cancer cells. Faseb J 23:425-432.